Importantly, Akt2-OE CTLs only induced an acute antitumor response without causing chronic liver damage, as evidenced by the transient serum ALT elevation in HCC mice receiving Akt2-OE CTLs (figure 2D,G). The gene discussed is AKT2; the disease is hepatocellular carcinoma.